Pharma, biotech cos low on VC radars

Healthcare in India is a large service sector in terms of revenues and is amongst the fastest growing markets. Experts point that from a market size of US$ 85 billion in 2013, the Indian healthcare is estimated to grow at 12-15% CAGR over the next decade .


Photo Courtesy:

This is primarily driven by increasing per capita disposable income, rising urbanization and growing health awareness, rapidly shifting disease patterns from acute to chronic, and growth in domestic healthcare infrastructure.

In the last two years, the healthcare and Life Sciences sectors have attracted over $2.3 billion worth of private equity (PE) investments, accounting for over 10 percent share of all PE investments done in India.

The Indian healthcare and lifesciences sector continues to be among the top five destinations for private equity investors in India.

Are VCs risk averse?

"In my view, within the Life Sciences space, VCs are highly risk averse to novel drug discovery investments given the very high failure rates involved. Aside of this, most other segments in lifesciences including generics, contract manufacturing, IT, discovery services, and retail, have all faced active investments by VCs," opined Ms Visalakshi Chandramouli, Partner - Healthcare Fund (Private Equity), Tata Capital.


Previous 1 3 4 5 6 7 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email